Kesler Norman & Wride’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$222K Sell
1,005
-323
-24% -$89.4K 0.04% 262
2026
Q1
$392K Sell
1,328
-272
-17% -$80.8K 0.07% 204
2025
Q4
$437K Sell
1,600
-616
-28% -$167K 0.07% 200
2025
Q3
$515K Sell
2,216
-689
-24% -$187K 0.1% 173
2025
Q2
$801K Sell
2,905
-298
-9% -$81K 0.14% 157
2025
Q1
$850K Buy
3,203
+987
+45% +$243K 0.16% 133
2024
Q4
$515K Buy
+2,216
New +$510K 0.11% 168

Other funds holding CME

Kesler Norman & Wride's CME Position: Q2 2026 in Review

Kesler Norman & Wride reduced its CME Group (CME) stake by 24% in Q2 2026, selling an estimated $89.4K and leaving 1,005 shares worth $222K. The position accounts for 0.04% of the portfolio, ranked #262.

Kesler Norman & Wride first reported a position in CME in Q4 2024 and has held it in 7 quarters since. The position peaked at $850K in Q1 2025. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Kesler Norman & Wride held 1,005 shares of CME Group worth $222K as of Q2 2026.
  • Kesler Norman & Wride sold 323 CME Group shares in Q2 2026, an estimated $89.4K.
  • CME Group made up 0.04% of Kesler Norman & Wride's portfolio in Q2 2026, its #262 holding.
  • Kesler Norman & Wride first reported a position in CME Group in Q4 2024 and has held it in 7 quarters since.
  • Kesler Norman & Wride's CME Group position peaked at $850K in Q1 2025.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Kesler Norman & Wride's 13F filing for Q2 2026, filed 23 Jul 2026.